Sex-Biased Alzheimer’s Variant

Women with a notorious variant of a gene involved in Alzheimer’s, APOE4, are much more likely than men with the variant to develop the neurodegenerative disease.

Apr 14, 2014
Kerry Grens

WIKIMEDIA, CHALMERS BUTTERFIELDFor decades, the gene APOE has been implicated in Alzheimer’s disease; namely, possessing a particular variant called APOE4 increases one’s risk of developing the disease. But such risk is not distributed equally, researchers reported today (April 14) in the Annals of Neurology. Healthy women with one copy of APOE4 are much more likely than male carriers to progress to mild cognitive impairment or to develop Alzheimer’s.

The results could help explain why, in general, women are at a greater risk for developing Alzheimer’s than men.

Although such a sex-bias had been hinted at nearly two decades ago, it was by and large ignored by the clinical and research communities, Michael Greicius, the medical director of the Stanford Center for Memory Disorders and one of the authors of the study, said in a press release. “I’d been practicing for five years before I ever heard of this paper, which had essentially been ignored for 10 years already,” he said.

Greicius and his colleagues collected data on nearly 8,000 men and women—some of whom had normal cognition and some who had mild cognitive impairment. Although all of those with APOE4 were more likely to develop Alzheimer’s than those without the variant, the risk was much smaller among the men. For instance, healthy men with APOE4 were 27 percent more likely to develop cognitive impairment or Alzheimer’s compared to those without the variant, while female carriers had an 80 percent greater risk.

The study doesn’t explain what’s behind the sex differences. Michelle Mielke, a psychiatric epidemiologist at the Mayo Clinic in Rochester, Minnesota, told NPR that a sex hormone might be involved. “What is interesting in relation to this paper is that animal and cellular studies suggest that there is an interaction between APOE4 and estrogen,” she said. “So that may possibly be explaining the findings we're seeing here in humans.”

The results may also influence the way carriers are handled clinically. Haydeh Payami, an Alzheimer’s researcher at the Wadsworth Center in Albany, New York, was among the first to notice APOE4’s sex bias. She told New Scientist that “it took 20 years, but I am glad that it's finally being recognized in a big way. Hopefully this time it will register for good: sex should be in the equation when dealing with APOE.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets


Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!